Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
23andMe Holding Co. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
ME
Nasdaq
8071
https://investors.23andme.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 23andMe Holding Co.
23andMe Aims To Raise Awareness of Lipoprotein(a), a Little-Known Genetic Risk Factor for Cardiovascular Disease
- Mar 24th, 2023 11:00 am
23andMe Holding (NASDAQ:ME) shareholders have endured a 41% loss from investing in the stock a year ago
- Mar 23rd, 2023 10:22 am
3 Key Ways That Artificial Intelligence Will Disrupt Biotech Stocks
- Mar 22nd, 2023 2:23 pm
WSJ. Magazine Celebrates Style & Tech in Silicon Valley
- Mar 17th, 2023 2:15 pm
23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the American Association for Cancer Research (AACR) Annual Meeting 2023
- Mar 14th, 2023 8:30 pm
AI Revolution on the Horizon: 2 High-Potential Growth Stocks to Watch in 2023
- Mar 9th, 2023 3:07 pm
New 23andMe Surveys Find Most People and Doctors Agree that Genetic Testing Offers Promise for More Personalized Healthcare
- Mar 9th, 2023 2:00 pm
2 Undervalued Growth Stocks With Long-Term Prospects That Are Ready to Rise
- Mar 2nd, 2023 12:30 pm
Asia’s Richest Man Mukesh Ambani to Foray Into Genome Testing with $145 Kit
- Mar 2nd, 2023 12:00 am
2 High-Growth Stocks That Could Double Your Money in 5 Years or Less
- Feb 28th, 2023 3:23 pm
23andMe Announces First Patient Dosed for the Phase 2a Portion of its Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 in Patients with Advanced Solid Malignancies
- Feb 28th, 2023 12:00 pm
23andMe to Present at Upcoming Investor Conferences
- Feb 22nd, 2023 9:05 pm
This Genetics Stock Could Have Massive Long-Term Potential
- Feb 10th, 2023 11:12 am
23andMe Holding Third Quarter 2023 Earnings: Beats Expectations
- Feb 10th, 2023 10:45 am
23andMe stock jumps more than 12% on raised 2023 guidance
- Feb 8th, 2023 9:50 pm
23andMe Reports FY2023 Third Quarter Financial Results
- Feb 8th, 2023 9:05 pm
Top 25 Smartest Companies To Buy According To Hedge Funds
- Feb 1st, 2023 3:16 pm
23andMe to Report FY2023 Third Quarter Financial Results
- Jan 26th, 2023 9:05 pm
3 Penny Stocks That Could Make You Filthy Rich
- Jan 25th, 2023 12:30 pm
Institutional investors own a significant stake of 37% in 23andMe Holding Co. (NASDAQ:ME)
- Jan 10th, 2023 1:25 pm
Scroll